Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Large Cell Carcinoma Lung”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00019513
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas

Who this might be right for
Colorectal CancerEsophageal CancerExtrahepatic Bile Duct Cancer+7 more
National Institutes of Health Clinical Center (CC) 108
Early research (Phase 1)Active Not RecruitingNCT06736418
What this trial is testing

Study of 225Ac-ABD147 to Establish Optimal Dose in Patients With SCLC and LCNEC of the Lung That Previously Received Platinum-based Chemotherapy

Who this might be right for
Small-Cell Lung Cancer (SCLC)Large Cell Neuroendocrine Carcinoma of the Lung
Abdera Therapeutics Inc. 17
Testing effectiveness (Phase 2)Study completedNCT00276588
What this trial is testing

Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 46
Testing effectiveness (Phase 2)Study completedNCT00425646
What this trial is testing

Imatinib Mesylate and Bevacizumab After First-Line Chemotherapy and Bevacizumab in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Washington 50
Early research (Phase 1)Active Not RecruitingNCT03132922
What this trial is testing

MAGE-A4ᶜ¹º³²T for Multi-Tumor

Who this might be right for
Urinary Bladder CancerMelanomaHead and Neck Cancer+7 more
USWM CT, LLC 71
Early research (Phase 1)Study completedNCT03329950
What this trial is testing

CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies

Who this might be right for
MelanomaNon-small Cell Lung CancerBreast Cancer+23 more
Celldex Therapeutics 132
Early research (Phase 1)Study completedNCT00009789
What this trial is testing

Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 39
Testing effectiveness (Phase 2)WithdrawnNCT02030184
What this trial is testing

Phase I/II Trial of Rhenium 188-P2045 in Small Cell Lung Cancer and Other Advanced Neuroendocrine Carcinomas

Who this might be right for
Small Cell Lung Cancer (SCLC)Neuroendocrine (NE) TumorsLarge Cell Neuroendocrine (NE) Tumors
University of Maryland, Baltimore
Testing effectiveness (Phase 2)UnknownNCT02943798
What this trial is testing

Optimization for the Treatment of Advanced Pulmonary Large Cell Neuroendocrine Carcinoma

Who this might be right for
Pulmonary Large Cell Neuroendocrine Carcinoma
Shanghai Chest Hospital 118
Testing effectiveness (Phase 2)Active Not RecruitingNCT04699838
What this trial is testing

Chemo-Immunotherapy Followed by Durvalumab and Ceralasertib in Treatment Naïve Patients With Extensive Stage Small Cell Lung Cancer

Who this might be right for
Extensive Stage Small Cell Lung Cancer
Muhammad Furqan 30
Large-scale testing (Phase 3)Study completedNCT00028938
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 1
Not applicableStudy completedNCT03351140
What this trial is testing

Patient-Reported Outcome Measurement Information System (PROMIS) Physical Function

Who this might be right for
Neoplasms
GlaxoSmithKline 1
Not applicableStudy completedNCT05337163
What this trial is testing

Clinical Trial of Sputum DNA Testing for Lung Cancer in China

Who this might be right for
Lung CancerSmall Cell Lung CancerNon-Small Cell Lung Cancer+13 more
Creative Biosciences (Guangzhou) Co., Ltd. 1,564
Large-scale testing (Phase 3)Study completedNCT01107626
What this trial is testing

Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
ECOG-ACRIN Cancer Research Group 1,516
Testing effectiveness (Phase 2)WithdrawnNCT00547443
What this trial is testing

Sorafenib and High-Dose Carboplatin, Paclitaxel, and External-Beam Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Texas Southwestern Medical Center
Early research (Phase 1)Ended earlyNCT00002947
What this trial is testing

Indium In 111 Pentetreotide in Treating Patients With Refractory Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Langerhans Cell HistiocytosisGastrointestinal Carcinoid Tumor+9 more
Yale University 35
Testing effectiveness (Phase 2)Ended earlyNCT03713944
What this trial is testing

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

Who this might be right for
NSCLC Stage IVNSCLC, Recurrent
Nasser Hanna 30
Testing effectiveness (Phase 2)Study completedNCT00979212
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Panitumumab in Treating Patients With Stage IIIA Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 71
Not applicableNo Longer AvailableNCT04507919
What this trial is testing

Managed Access Program Cohort Treatment Plan CTMT212X2002I to Provide Access to Trametinib and Dabrafenib Combination Therapy for Patients With BRAF V600 Mutation-positive Advanced Non-Small Cell Lung Cancer

Who this might be right for
Small Cell Lung Carcinoma
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Active Not RecruitingNCT05208944
What this trial is testing

THIO Sequenced With Cemiplimab in Advanced NSCLC

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Maia Biotechnology 227
Next Page